Position
BRAIDWELL LP in Apogee Therapeutics, Inc.
Back to the book · All holders of APGE
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $4.16M$75.48 → $84.17
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 575.1K | $43.4M | — | — | — | 1.4% |
| Q1 2026 | 478.7K | $40.3M | $84.17 | $4.16M | −$7.28M | 1.3% |